Physician profile
Mark D Sack
NPI 1548286313
$1,613.59
in general payments reported to CMS, 2019-2025
12 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $273 · 2021: $102 · 2022: $13.06 · 2023: $336 · 2024: $160 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $445.53 | 2019-2025 | Stravix, Grafix, Oasis |
| Wright Medical Technology, INC. | $440.48 | 2019-2020 | |
| Organogenesis INC. | $330.32 | 2022-2025 | Puraply, Apligraf |
| Depuy Synthes Sales INC. | $128.70 | 2020-2025 | Motoband, Na |
| Stryker Corporation | $85.64 | 2025 | Actishield, Augment Injectable |
| Medline Industries Lp | $76.66 | 2023 | |
| Paragon 28, INC. | $29.40 | 2025 | Tenotac |
| Abbott Laboratories | $18.63 | 2024 | Proclaim |
| Integra Lifesciences Corporation | $18.17 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lifenet Health | $17.27 | 2023 | |
| Osteomed LLC | $15.65 | 2020 | |
| Electronic Waveform Lab, INC. | $7.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.